Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents.

Palekar, Rohun U; Jallouk, Andrew P; Lanza, Gregory M; Pan, Hua; Wickline, Samuel A

Palekar, Rohun U; Jallouk, Andrew P; Lanza, Gregory M; Pan, Hua; Wickline, Samuel A.

Afiliação

Palekar RU; Department of Biomedical Engineering, Washington University, Whitaker Hall, Campus Box 1097, One Brookings Drive, St. Louis, MO 63130, USA.
Jallouk AP; Department of Medicine, Washington University, Campus Box 8215, 4320 Forest Park Avenue, St Louis, MO 63108, USA.
Lanza GM; Department of Biomedical Engineering, Washington University, Whitaker Hall, Campus Box 1097, One Brookings Drive, St. Louis, MO 63130, USA.
Pan H; Department of Medicine, Washington University, Campus Box 8215, 4320 Forest Park Avenue, St Louis, MO 63108, USA.
Wickline SA; Department of Medicine, Washington University, Campus Box 8215, 4320 Forest Park Avenue, St Louis, MO 63108, USA.

Nanomedicine (Lond) ; 10(11): 1817-32, 2015.

Article em En | MEDLINE | ID: mdl-26080701

Assuntos

Aterosclerose/diagnóstico por imagem; Meios de Contraste/uso terapêutico; Nanopartículas/uso terapêutico; Placa Aterosclerótica/diagnóstico por imagem; Aterosclerose/patologia; Meios de Contraste/química; Humanos; Imageamento por Ressonância Magnética/métodos; Imagem Molecular/métodos; Placa Aterosclerótica/patologia; Radiografia

Palavras-chave

atherosclerosis; contrast agent; inflammation; theranostics; thrombosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Meios de Contraste / Aterosclerose / Nanopartículas / Placa Aterosclerótica Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google